Welcome to LookChem.com Sign In|Join Free
  • or
Carbamic acid, [(1S)-2-[4-[(2-methyl-4-thiazolyl)methoxy]phenyl]-1-(2S)-oxiranylethyl]-, 1,1-dimethylethyl ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

313680-92-1

Post Buying Request

313680-92-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

313680-92-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 313680-92-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,1,3,6,8 and 0 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 313680-92:
(8*3)+(7*1)+(6*3)+(5*6)+(4*8)+(3*0)+(2*9)+(1*2)=131
131 % 10 = 1
So 313680-92-1 is a valid CAS Registry Number.

313680-92-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-butyl N-[(1S)-2-[4-[(2-methyl-1,3-thiazol-4-yl)methoxy]phenyl]-1-[(2S)-oxiran-2-yl]ethyl]carbamate

1.2 Other means of identification

Product number -
Other names TERT-BUTYL [(1S)-2-[4-[(2-METHYL-THIAZOL-4-YL)METHOXY]PHENYL]-1-(2S)-OXIRANYLETHYL]-CARBAMATE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:313680-92-1 SDS

313680-92-1Downstream Products

313680-92-1Relevant academic research and scientific papers

Inhibitors of aspartyl protease

-

Page 132-133, (2008/06/13)

The present invention relates to a novel class of sulfonamides which are aspartyl protease inhibitors. In one embodiment, this invention relates to a novel class of HIV aspartyl protease inhibitors characterized by specific structural and physicochemical features. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting HIV-1 and HIV-2 protease activity and consequently, may be advantageously used as anti-viral agents against the HIV-1 and HIV-2 viruses. This invention also relates to methods for inhibiting the activity of HIV aspartyl protease using the compounds of this invention and methods for screening compounds for anti-HIV activity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 313680-92-1